Skip to content

FDA recalls blood pressure medication over cancer risks

According to the Food and Drug Administration (FDA), Lupine Pharmaceuticals Inc. is recalling four lots of its blood pressure drug quinapril tablets after recent testing of the product detected impurities known as nitrosamines.

The FDA said no illnesses related to the drug had been reported yet and sales of Quinapril tablets ended in September. Quinapril is an angiotensin-converting enzyme inhibitor used to treat high blood pressure to lower blood pressure.

The tablets were contaminated with substances known as nitrosamines.These impurities are found in meat, dairy and vegetables and may increase the risk of developing cancer if faced with prolonged exposure, according to the FDA. there is.

People taking quinapril tablets are advised by the FDA to continue taking their medication until they contact their health care professional for personal advice on alternative medications.

However, retailers have been instructed to stop selling Quinapril tablets immediately.

Anyone with questions regarding the quinapril recall has been directed by the FDA to contact Inmar Rx Solutions Inc. at (877) 538-8445, Monday through Friday, 9:00 am to 5:00 pm.